YiChang HEC Executes Key Derivative Contracts

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.

YiChang HEC ChangJiang Pharmaceutical Co. Ltd. has disclosed a transaction involving the closing out of derivative contracts by CICC Financial Trading Limited on May 20, 2024, totaling approximately $171,466.10. The dealings were in connection with a privatisation by way of merger, and CICC, an exempt principal trader linked to the offeror, conducted the transactions for its own account.

For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.